Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

June 3, 2019 Issue

09722-cover-opener.jpg

June 3, 2019 Cover

Volume 97, Issue 22

The cellular housecleaning and self-renewal process is implicated in neurodegenerative diseases, cancer, and more. Can biotech companies walk the fine line between boosting and inhibiting autophagy to treat disease without causing it?

Cover image:Autophagy, the process of cellular housecleaning and self-renewal, is implicated in neurodegenerative diseases, cancer, and more. Can biotech companies walk the fine line between boosting and inhibiting autophagy to treat disease without causing it?

Credit: Chris Gash

Full Article
Start-ups

Autophagy: Drugging the yin and yang of the cell

The cellular housecleaning and self-renewal process is implicated in neurodegenerative diseases, cancer, and more. Can biotech companies walk the fine line between boosting and inhibiting autophagy to treat disease without causing it?

  • From our archives: An essay on selenium, by Liu Tungsheng

    To celebrate the International Year of the Periodic Table, C&EN is re-releasing its favorite essays from a special 2003 collectors’ issue celebrating the elements

  • US hemp boom creates chaos

    Companies struggle with varying state laws, lack of federal guidance

  • Career Ladder: Anne Mallaband

    This English chemist worked in industry before moving to academia and European science policy

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT